Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(33.3%)
Phase 2
1(33.3%)
Phase 4
1(33.3%)
3Total
N/A(1)
Phase 2(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06696820Phase 2Recruiting

Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke

Role: collaborator

NCT04852562Not ApplicableCompleted

The Effect of Modified Radical Endoscopic Sinus Surgery on Eosinopilic Chronic Rhinosinusitus With Nasal Polyps

Role: collaborator

NCT04932200Unknown

The Timing of Emergency Endoscopy for Esophagogastric Variceal Bleeding in Cirrhosis

Role: collaborator

NCT01293903Phase 4Completed

Study of Qiliqiangxin Capsule to Treat Dilated Cardiomyopathy

Role: collaborator

All 4 trials loaded